Caleb Webber

Caleb obtained his PhD in 2003 from the European Bioinformatics Institute, The Wellcome Trust Genome Campus, Hinxton Cambridge and from the Department of Genetics, Cambridge University. He is the leader of the Neurological Disease Genomics Group from the Department of Physiology, Anatomy and Genetics of Oxford University. He aims to develop, apply and validate bioinformatics network and systems approaches to the analysis of Omics data in order to etiologically stratify and treat human neurological disorders. His current roles include being the Genomics and Computational Biology lead at Oxford Parkinson’s Disease Centre and the Target Identification lead at the Alzheimer’s Research UK Oxford Drug Discovery Institute. He is strongly collaborative with many European and International partnerships, especially through the IMI StemBANCC consortium (Stem cells for biological assays of novel drugs and predictive toxicology), where he leads the Data Analyses work package.